This VIAF Cluster has been deleted. It is no longer part of VIAF.
Asuncion Mejias
Mejías, Asunción
VIAF ID: 164146284411315332225 (Unknown Name Type)
Permalink: http://viaf.org/viaf/164146284411315332225
Preferred Forms
- 100 0 _ ‡a Asuncion Mejias
- 100 1 _ ‡a Mejías, Asunción
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Impact of an influenza vaccine educational programme on healthcare personnel. | |
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. | |
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination | |
Infecciones por virus respiratorio sincitial. Antiguos retos y nuevas estrategias | |
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. | |
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever. | |
Interferon gene expression as marker of immune maturation and response to vaccination | |
Intravenous palivizumab in respiratory syncytial virus infection after hematopoietic stem cell transplant in children. | |
It is time for a comprehensive analytical approach in clinical studies. Virus-versus-host interaction and influenza disease severity. | |
The Journey to an RSV Vaccine | |
Letters to the Editors | |
Live Attenuated Vaccine With a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children | |
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus | |
Mapping systemic lupus erythematosus heterogeneity at the single-cell level | |
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus | |
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. | |
Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018 | |
Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia | |
Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model | |
New approaches to reduce the burden of RSV infection | |
Novedades en el tratamiento de la bronquiolitis: perspectivas en el 2013 | |
P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy | |
[Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform] | |
Pediatric drug-resistant tuberculosis in Madrid: family matters. | |
Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. | |
Persistent and transient Helicobacter pylori infections in early childhood. | |
Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. | |
Predictors for successful treatment of pediatric deep neck infections using antimicrobials alone. | |
Prevalence, Genotypes, Clinical Manifestations and Outcomes Associated with Human Parechovirus (HPeV) Infections in Infants up to 2 Months old in Central Ohio. | |
Promise and Limitations of Procalcitonin to Identify Bacterial Infections in the Pediatric Intensive Care Unit. | |
Re: "Discharge Criteria for Bronchiolitis: Does Age Matter?" | |
Recent Trends in RSV Immunoprophylaxis: Clinical Implications for the Infant | |
Reduced Numbers of T-Cell, B-Cell, and CD4+ Follicular Helper T Cell (Tfh) Populations in Infants With Acute Respiratory Syncytial Virus (RSV) Infection | |
Reply to Plötz et al. | |
Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. | |
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. | |
Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. | |
Respiratory syncytial virus: old challenges and new approaches. | |
Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. | |
Respiratory Syncytial Virus, Rhinoviruses, and Recurrent Wheezing: Unraveling the Riddle Opens New Opportunities for Targeted Interventions | |
Respiratory Syncytial Virus Seasonality: A Global Overview. | |
Respiratory viruses identified in an urban children's hospital emergency department during the 2009 influenza A(H1N1) pandemic. | |
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants. | |
Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. | |
Rhinovirus - not just the common cold. | |
Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life. | |
Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. | |
RNA signature test to distinguish bacterial from viral infection. | |
RNA transcriptional biosignature analysis for identifying febrile infants with serious bacterial infections in the emergency department: a feasibility study. | |
Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis | |
Serratia Species | |
Shifting the Paradigm: Host Gene Signatures for Diagnosis of Infectious Diseases | |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. | |
Systems immunology: Beyond antibody titers. | |
[Testing for respiratory viruses in the neonatal intensive care unit: Ready for prime time?]. | |
Transcriptional profiling in infectious diseases: ready for prime time? | |
Treatment of experimental chronic pulmonary mycoplasmosis | |
Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Transplant Recipients | |
Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. | |
Viral Bacterial Interactions in Children: Impact on Clinical Outcomes | |
Viral coinfections in children with invasive pneumococcal disease. | |
Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. | |
Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease. | |
Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis | |
Year-round, Routine Testing of Multiple Body Site Specimens for Human Parechovirus in Young Febrile Infants |